Skip to main content
SpringerLink
Log in
Book cover

Vestibular Schwannoma Surgery pp 1–13Cite as

Acoustic Neuromas: General Considerations

  • Chapter
  • First Online:

  • 652 Accesses

Abstract

VS account for approximately 6–8% of intracranial tumors in adults and are the most common tumor in the CPA ranging between 80% and 95%. Vestibular schwannomas constitute 6% of all intracranial neoplasms and are the most common benign lesions of the IAC and CPA cistern constituting between 60% and 90% of the entire lesions seen in this area. Growth rates in tumors that exhibit enlargement have been reported to be about 1–2 mm per year in linear growth in at least one dimension. While no formal consensus exists, most authors define normal growth rates as being between 1 and 2 mm per year and fast growth rates as 4 mm or greater per year. When considering common presenting manifestations, a helpful framework is to consider manifestations based on the size of the tumor, and its location; intracanalicular, cisternal, brainstem compressive, or hydrocephalic sizes. While any configuration is possible, hearing loss associated with vestibular schwannomas of this size is typically unilateral, progressive, and commonly affects high-frequency thresholds and speech perception. An occipital headache attributable to the tumor is a late finding with 20% of patients with tumors between 1 and 3 cm, with 40% of patients with tumors larger than 3 cm verifying this symptom. Gross total resection is the goal of surgery while maintaining good facial function, in all sizes of tumors, and hearing preservation, in small to moderate size tumors in patients with serviceable preoperative hearing status.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Khrais T, Romano G, Sanna M. Nerve origin of vestibular schwannoma: a prospective study. J Laryngol Otol. 2008;122(2):128–31.

    Article  CAS  PubMed  Google Scholar 

  2. Angelika Z, et al. Management of benign cranial nonacoustic schwannomas by fractionated stereotactic radiotherapy. Int J Cancer. 2001;96(6):356–62.

    Article  Google Scholar 

  3. Lin EP, Crane BT. The management and imaging of vestibular schwannomas. AJNR Am J Neuroradiol. 2017;38(11):2034–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Mahaley MS Jr, et al. Analysis of patterns of care of brain tumor patients in the United States: a study of the Brain Tumor Section of the AANS and the CNS and the Commission on Cancer of the ACS. Clin Neurosurg. 1990;36:347–52.

    PubMed  Google Scholar 

  5. Horváth M, et al. Tumors of the cerebellopontine angle. Changing policy in treatment. Neurosurg Rev. 1996;19(4):243–6.

    Article  PubMed  Google Scholar 

  6. Betka J, et al. Complications of microsurgery of vestibular schwannoma. Biomed Res Int. 2014;2014:315952.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Moffat DA, Ballagh RH. Rare tumours of the cerebellopontine angle. Clin Oncol. 1995;7(1):28–41.

    Article  CAS  Google Scholar 

  8. Springborg JB, Poulsgaard L, Thomsen J. Nonvestibular schwannoma tumors in the cerebellopontine angle: a structured approach and management guidelines. Skull Base. 2008;18(4):217–27.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hasegawa M, et al. Cerebellopontine angle epidermoid cysts: clinical presentations and surgical outcome. Neurosurg Rev. 2016;39(2):259–66. discussion 266–7.

    Article  PubMed  Google Scholar 

  10. Ramsden RT. The bloody angle: 100 years of acoustic neuroma surgery. J R Soc Med. 1995;88(8):464P–8P.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Cushing H. Tumors of the nervus acusticus and the syndrome of the cerebellopontine angle. Philadelphia: Saunders; 1917.

    Google Scholar 

  12. Brackmann DE. Vestibular schwannoma (acoustic neuroma). Otolaryngol Clin N Am. 2012;45(2):xiii–xv.

    Article  Google Scholar 

  13. Pellet W. History of vestibular schwannoma surgery. Prog Neurol Surg. 2008;21:6–23.

    Article  PubMed  Google Scholar 

  14. Koerbel A, et al. Evolution of vestibular schwannoma surgery: the long journey to current success. Neurosurg Focus. 2005;18(4):e10.

    PubMed  Google Scholar 

  15. Alfaifi A, et al. The top 50 most-cited articles on acoustic neuroma. World Neurosurg. 2018;111:e454–64.

    Article  PubMed  Google Scholar 

  16. Dandy WE. Removal of cerebellopontile (acoustic) tumors through a unilateral approach. Arch Surg. 1934;29(3):337–44.

    Article  Google Scholar 

  17. Horrax G, Poppen JL, Strain RE. Results of present day operations for acoustic tumors. Lahey Clin Bull. 1949;6(4):109–11.

    CAS  PubMed  Google Scholar 

  18. House WF. Transtemporal bone microsurgical removal of acoustic neuromas. evolution of transtemporal bone removal of acoustic tumors. Arch Otolaryngol. 1964;80:731–42.

    Article  CAS  PubMed  Google Scholar 

  19. Hitselberger WE, House WF. Surgical approaches to acoustic tumors. Arch Otolaryngol. 1966;84(3):286–91.

    Article  CAS  PubMed  Google Scholar 

  20. Brackmann DE, Bartels LJ. Rare tumors of the cerebellopontine angle. Otolaryngol Head Neck Surg (1979). 1980;88(5):555–9.

    Article  CAS  Google Scholar 

  21. Marcel Maya M, Lo WWM, Kovanlikaya I. Temporal bone: tumor and cerebellopontine angle lesions. In: Som PM, Curtin HD, editors. Head and neck imaging. St. Louis, MO: Mosby; 2003.

    Google Scholar 

  22. Propp JM, et al. Descriptive epidemiology of vestibular schwannomas. Neuro-Oncology. 2006;8(1):1–11.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Lee A, Chao S, Murphy E. Acoustic neuroma. Appl Radiat Oncol. 2013;2(1):24–6.

    Google Scholar 

  24. Evans DGR, Birch JM, Ramsden RT. Paediatric presentation of type 2 neurofibromatosis. Arch Dis Child. 1999;81(6):496–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Howitz MF, et al. Incidence of vestibular schwannoma in Denmark, 1977-1995. Am J Otol. 2000;21(5):690–4.

    CAS  PubMed  Google Scholar 

  26. Nestor JJ, et al. The incidence of acoustic neuromas. Arch Otolaryngol Head Neck Surg. 1988;114(6):680.

    Article  CAS  PubMed  Google Scholar 

  27. Tos M, et al. What is the real incidence of vestibular schwannoma? Arch Otolaryngol Head Neck Surg. 2004;130(2):216–20.

    Article  PubMed  Google Scholar 

  28. Abele TA, et al. Diagnostic accuracy of screening MR imaging using unenhanced axial CISS and coronal T2WI for detection of small internal auditory canal lesions. AJNR Am J Neuroradiol. 2014;35(12):2366–70.

    Article  CAS  PubMed  Google Scholar 

  29. Liudahl AA, et al. Diagnosis of small vestibular schwannomas using constructive interference steady state sequence. Laryngoscope. 2018. https://doi.org/10.1002/lary.27100.

    Article  PubMed  Google Scholar 

  30. Anderson TD, et al. Prevalence of unsuspected acoustic neuroma found by magnetic resonance imaging. Otolaryngol Head Neck Surg. 2000;122(5):643–6.

    Article  CAS  PubMed  Google Scholar 

  31. Lin D, et al. The prevalence of “incidental” acoustic neuroma. Arch Otolaryngol Head Neck Surg. 2005;131(3):241–4.

    Article  PubMed  Google Scholar 

  32. Stangerup SE, Caye-Thomasen P. Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin N Am. 2012;45(2):257–68, vii.

    Article  PubMed  Google Scholar 

  33. M, H. and C. SJ. Early asymptomatic acoustic tumor. Report of six cases. Arch Surg. 1936;32:292–301.

    Article  Google Scholar 

  34. Leonard JR, Talbot ML. Asymptomatic acoustic neurilemoma. Arch Otolaryngol. 1970;91(2):117–24.

    Article  CAS  PubMed  Google Scholar 

  35. Stangerup SE, et al. True incidence of vestibular schwannoma? Neurosurgery. 2010;67(5):1335–40. discussion 1340.

    Article  PubMed  Google Scholar 

  36. Lee KS, et al. The proliferative activity of neurilemomas. Surg Neurol. 1989;32(6):427–33.

    Article  CAS  PubMed  Google Scholar 

  37. Lesser TH, et al. Clinical growth rate of acoustic schwannomas: correlation with the growth fraction as defined by the monoclonal antibody ki-67. Skull Base Surg. 1991;1(1):11–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Bederson JB, et al. Conservative treatment of patients with acoustic tumors. Neurosurgery. 1991;28(5):646–50. discussion 650–1.

    Google Scholar 

  39. Kesterson L, et al. Clinical behavior of acoustic tumors. A flow cytometric analysis. Arch Otolaryngol Head Neck Surg. 1993;119(3):269–71.

    Article  CAS  PubMed  Google Scholar 

  40. Pasquier B, et al. Evaluation of the acoustic neuroma growth rate by immunohistochemical techniques. In: Tos M, Thomsen J, editors. Proceeding of the first international conference on acoustic neuroma, Amsterdam; 1992. p. 173–6.

    Google Scholar 

  41. Nedzelski JM, et al. Conservative management of acoustic neuromas. Otolaryngol Clin N Am. 1992;25(3):691–705.

    CAS  Google Scholar 

  42. Selesnick SH, Johnson G. Radiologic surveillance of acoustic neuromas. Am J Otol. 1998;19(6):846–9.

    CAS  PubMed  Google Scholar 

  43. Battaglia A, Mastrodimos B, Cueva R. Comparison of growth patterns of acoustic neuromas with and without radiosurgery. Otol Neurotol. 2006;27(5):705–12.

    Article  PubMed  Google Scholar 

  44. Mirz F, et al. Incidence and growth pattern of vestibular schwannomas in a Danish county, 1977-98. Acta Otolaryngol Suppl. 2000;543:30–3.

    CAS  PubMed  Google Scholar 

  45. Shin YJ, et al. Effectiveness of conservative management of acoustic neuromas. Am J Otol. 2000;21(6):857–62.

    CAS  PubMed  Google Scholar 

  46. Hoistad DL, et al. Update on conservative management of acoustic neuroma. Otol Neurotol. 2001;22(5):682–5.

    Article  CAS  PubMed  Google Scholar 

  47. Tschudi DC, Linder TE, Fisch U. Conservative management of unilateral acoustic neuromas. Am J Otol. 2000;21(5):722–8.

    CAS  PubMed  Google Scholar 

  48. Strasnick B, et al. The natural history of untreated acoustic neuromas. Laryngoscope. 1994;104(9):1115–9.

    Article  CAS  PubMed  Google Scholar 

  49. Bakkouri WE, et al. Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment. J Neurosurg. 2009;110(4):662–9.

    Article  PubMed  Google Scholar 

  50. Baser M, et al. Evaluation of genotype-phenotype correlations for vestibular schwannoma growth rates in neurofibromatosis 2. In: Fourth international conference on vestibular schwannoma and other CPA lesions, Cambridge, England; 2003.

    Google Scholar 

  51. Lanser M, Jackler R, Pitts L. Intratumoral hemorrhage and cyst expansion as causes of acute neurological deterioration in acoustic neuroma patients. In:Proceeding of the first international conference on acoustic neuroma. Amsterdam: Kugler; 1992.

    Google Scholar 

  52. Stangerup SE, et al. The natural history of vestibular schwannoma. Otol Neurotol. 2006;27(4):547–52.

    PubMed  Google Scholar 

  53. Hunter JB, et al. Single institutional experience with observing 564 vestibular schwannomas: factors associated with tumor growth. Otol Neurotol. 2016;37(10):1630–6.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Stangerup SE, et al. Change in hearing during ‘wait and scan’ management of patients with vestibular schwannoma. J Laryngol Otol. 2008;122(7):673–81.

    Article  PubMed  Google Scholar 

  55. Stangerup SE, et al. Long-term hearing preservation in vestibular schwannoma. Otol Neurotol. 2010;31(2):271–5.

    Article  PubMed  Google Scholar 

  56. Stangerup SE, et al. Hearing outcomes of vestibular schwannoma patients managed with ‘wait and scan’: predictive value of hearing level at diagnosis. J Laryngol Otol. 2010;124(5):490–4.

    Article  PubMed  Google Scholar 

  57. Elliott A, et al. Hearing preservation in vestibular schwannoma management. Am J Otolaryngol. 2015;36(4):526–34.

    Article  PubMed  Google Scholar 

  58. Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery. 1997;40(1):1–9. discussion 9–10.

    CAS  PubMed  Google Scholar 

  59. Harner SG, Fabry DA, Beatty CW. Audiometric findings in patients with acoustic neuroma. Am J Otol. 2000;21(3):405–11.

    Article  CAS  PubMed  Google Scholar 

  60. Thomsen J, Tos M. Acoustic neuroma: clinical aspects, audiovestibular assessment, diagnostic delay, and growth rate. Am J Otol. 1990;11(1):12–9.

    CAS  PubMed  Google Scholar 

  61. Selesnick SH, Jackler RK. Atypical hearing loss in acoustic neuroma patients. Laryngoscope. 1993;103(4 Pt 1):437–41.

    Article  CAS  PubMed  Google Scholar 

  62. Edwards CH, Paterson JH. A review of the symptoms and signs of acoustic neurofibromata. Brain. 1951;74(2):144–90.

    Article  CAS  PubMed  Google Scholar 

  63. Simon C, Brichet B, Decroocq F. An electromyographic study of the facial nerve and its innervation territy by detection, stimulo-detection, and blink reflex in preoperative acoustic neuroma. In:Proceeding of the First International Conference on Acoustic Neuroma. Amsterdam: Kugler; 1992.

    Google Scholar 

  64. Zubay G, Porter RW, Spetzler RF. Neurofibromatosis. Oper Tech Neurosurg. 2001;4(1):43–6.

    Article  Google Scholar 

  65. Rouleau GA, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 1993;363:515.

    Article  CAS  PubMed  Google Scholar 

  66. Obremski VJ, Hall AM, Fernandez‐Valle C. Merlin, the neurofibromatosis type 2 gene product, and β1 integrin associate in isolated and differentiating Schwann cells. J Neurobiol. 1998;37(4):487–501.

    Article  CAS  PubMed  Google Scholar 

  67. Prasad SC, et al. Decision making in the wait-and-scan approach for vestibular schwannomas: is there a price to pay in terms of hearing, facial nerve, and overall outcomes? Neurosurgery. 2017. https://doi.org/10.1093/neuros/nyx568.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    Ihsan Dogan, Burak Ozaydin & Mustafa K. Baskaya

  2. Department of Surgery, Division of Otolaryngology-Head and Neck Surgery, Section of Otology/Neurotology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    Joseph P. Roche

Authors
  1. Ihsan Dogan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Burak Ozaydin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joseph P. Roche
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mustafa K. Baskaya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mustafa K. Baskaya .

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dogan, I., Ozaydin, B., Roche, J.P., Baskaya, M.K. (2019). Acoustic Neuromas: General Considerations. In: Vestibular Schwannoma Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-99298-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-99298-3_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-99297-6

  • Online ISBN: 978-3-319-99298-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation